Enhancing Success and Satisfaction: Principles of Effective Teaming for Clinicians and Leaders
KyleTurner, Pharm.D., BCACP
UAN: 0107-9999-21-161-H04-P
0107-9999-21-161-H04-T
Knowledge-based | 0.1 CEU /1.0 Hr
Session Objectives
- Describe the characteristics of high performing teams
- Explain how Tuckman’s Stages of Teaming apply to a current professional situation
- Identify a plan to enhance success and satisfaction within one’s own team
Non-Prescription Medications and Self-Care Refresher
MichelleHon, BA, MA, Pharm.D
UAN: 0107-9999-21-162-H04-P
0107-9999-21-162-H04-T
Knowledge-based | 0.1 CEU /1.0 Hr
Session Objectives:
- Describe the basic cause(s) and occurrence of each condition covered
- Recognize the signs/symptoms of the condition
- Identify basic self-care guidelines, including appropriate OTC product selection and use, non-drug measures, and expected outcomes
- Identify when appropriate provider-referral is needed
Point of Care Testing Services
Van Luu, PharmD.
UAN: 0107-9999-21-163-H04-P
0107-9999-21-163-H04-T
Knowledge-based | 0.1 CEU /1.0 Hr
Session Objectives
- Review the state of Utah’s point of care testing (POCT) services available in the community pharmacy setting including, cholesterol screening, blood glucose, hemoglobin A1c tests, and COVID-19 antibody testing.
- Discuss and summarize testing recommendations for additional POCT opportunities not widely adopted in Utah community pharmacies including, group Astreptococcus, influenza, hepatitisC, HIV, and INR testing.
- Describe how POCT may be utilized along side collaborative practice agreement, standing order, or prescriptive authority in community pharmacy practice as part of an innovative practice model.
- Discuss the impact of POCT on improving patient health outcomes
- Review current CLIA waived POCT products and the requirements to obtain CLIA waivers for future POCT services in the community pharmacy setting.
CPhT to PharmD: Career Considerations and Applying to Pharmacy School (Technicians)
NickCox, PharmD, BCACP
Dustin Christensen-Grant, PharmD, BCPS
UAN: 0107-9999-21-164-H04-T
Knowledge-based | 0.1 CEU/1.0 Hr
Session Objectives
- Identify factors related to pharmacy technicians applying to pharmacy school and becoming a pharmacist
- Describe general pharmacy school application requirements
- Explain a competitive pharmacy school application
Beyond "Self-Care": Addressing Burnout in the Pharmacy Profession
Alisyn May, PharmD, BCACP, CDCES
UAN: 0107-9999-21-165-H04-P
0107-9999-21-165-H04-T
Knowledge-based | 0.15 CEU /1.5 Hr
Session Objectives:
- Describe burnout rates among pharmacists and pharmacy technicians
- Identify literature regarding causes and contributors of burnout and resilience among the pharmacy profession
- Outline interventions to prevent and manage burnout in pharmacists and pharmacy technicians
- Outline an individual action plan to prevent and manage personal burnout
Immunization Overdrive: Updates and Tips for Survival in 2021
Karen Gunning, PharmD, BCPS, BCACP, FCCP
Professor (Clinical) and Associate Dean of Community Engagement
Adjunct Professor of Family & Preventive Medicine
University of Utah College of Pharmacy, and School of Medicine
UAN: 0107-9999-21-166-H06-P
0107-9999-21-166-H06-T
Knowledge-based | 0.2 CEU /2.0 Hr
Pharmacist Objectives:
- Compare and contrast the 2021 ACIP Schedules with previous years and incorporate those changes into your immunization practice.
- Develop a general counseling plan for COVID-19 vaccines, including a discussion of efficacy and adverse effects.
- Identify areas of potential vaccine error and develop a process to reduce errors in the storage, handling and administration of vaccines.
- Define “SIRVA” and be able to develop a plan to reduce the frequency of this adverse effect.
Technician Objectives:
- Compare and contrast the 2021 ACIP Schedules with previous years and incorporate those changes into your immunization practice.
- Review available COVID-19 vaccines, and be able to differentiate between the different vaccines in terms of storage, administration and dosing.
- Identify areas of potential vaccine error and develop a process to reduce errors in the storage, handling and administration of vaccines.
- Define “SIRVA” and be able to develop a plan to reduce the frequency of this adverse effect.
SGLT-2 Inhibitors: Updates and Best Practices
ShannonGadd, Pharm.D.
UAN: 0107-9999-21-167-H01-P
0107-9999-21-167-H01-T
Knowledge-based | 0.15 CEU /1.5 Hr
Session Objectives:
- Review recent literature regarding the use of Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors
- Determine the appropriate use of SGLT2 inhibitors in heart failure and diabetes
- Identify safe prescribing practices forSGLT-2 inhibitors
- Identify the role of the pharmacy team in the use ofSGLT-2 inhibitors
Understanding the Expanding Role of Pharmacy Services in Outpatient CF Care:
What CanTeamRx Do 4 U
Dave Young, Pharm.D. – Chronic CF medication update
Lynda Roe, Specialty Pharmacy Technician– CF copay assistance update
Justin Moss, CPhT– Role of Pharmacy Technician(s) in Outpatient Cystic Fibrosis Care
Jeffery Zobell, Pharm.D., BCPPS – Evolving Outpatient Pharmacy Servicesin Cystic Fibrosis Care
UAN: 0107-9999-21-168-H01-P
0107-9999-21-168-H01-T
Knowledge-based | 0.15 CEU /1.5 Hr
Session Objectives:
- Explain the chronic medications utilized in the care of cystic fibrosis (CF) patients
- Identify the various copay assistance programs utilized for CF medications
- Describe the role of pharmacy technicians in outpatient CF care
- Explain the available literature highlighting the evolution of outpatient CF pharmacy services
Healthcare by the Numbers
MichaelWright, R.Ph.
UAN: 0107-9999-21-169-H04-P
0107-9999-21-169-H04-T
Knowledge-based | 0.15 CEU /1.5 Hr
Session Objectives
- Discuss weight, blood pressure, cholesterol, blood sugar, and common lab tests and what their values should be.
- Describe health risks associated with out of range values.
- Discuss the prevalence of issues regarding these measurements.
- Identify current treatments for these conditions.
Diabetes-Related Complications: The “Onerous Opathies” and Macrovascular Disease
LauraShane-McWhorter, PharmD, BCPS, BC-ADM, CDCES, FASCP, FADCES
UAN: 0107-9999-21-170-H01-P
0107-9999-21-170-H01-T
Knowledge-based | 0.15 CEU /1.5 Hr
Session Objectives
- Describe the major microvascular and macrovascular complications of diabetes.
- Describe the importance of maintaining glucose at optimal levels.
- List treatment strategies for microvascular complications, including retinopathy, neuropathy, and nephropathy.
- Discuss treatment strategies for macrovascular complications, including hypertension, hyperlipidemia, and heart failure.
REGISTER ONLINE
*Once you are registered, a thank you confirmation will be emailed to you and give you the link to the conference
Print Page